Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs IQIYI Inc - ADR (IQ) Price & Performance

Cronos Group IncTrade
IQIYI Inc - ADRTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs IQIYI Inc - ADR — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while IQIYI Inc - ADR trades at $1.17 (market cap $1.12B). The key difference: Cronos Group Inc and IQIYI Inc - ADR are close in size by market cap, and Cronos Group Inc is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals.

CRONIQ
Market Cap
$1.02B$1.12B
Sector
HealthMedia
52-Week High
$3.27$2.79
52-Week Low
$1.95$0.96
Enterprise Value
$203.29M$2.69B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.

Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.

IQIYI Inc - ADR

iQIYI (IQ) trades at $1.13 with no recent price movement, showing mixed technical signals with a bullish moving average trend but neutral oscillators. The company reported Q1 2026 revenue decline of 13% year-over-year to $915.2M, missing expectations, though it beat EPS estimates. Valuation metrics show a high P/E ratio of 144.05 but attractive P/S of 0.29 and P/B of 0.57. Recent leadership changes and AI platform expansion highlight strategic shifts amid challenging fundamentals.

The outlook remains cautious with declining revenues and negative profitability margins creating headwinds. Analyst consensus leans bullish with 50% buy ratings, but execution risks and competitive pressures in China's streaming market pose significant challenges. The stock's current valuation disconnect between high P/E and low price-to-sales metrics suggests potential for recovery if AI initiatives drive growth, but near-term volatility is expected.

Returns comparison

Trailing returns across standard periods

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About IQIYI Inc - ADR

iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.

Read more on IQ